4/A
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0001209191-05-065703
Chairman/CEO/CFO/Secretary sold 205,000 shares at an average $0.18 ($36,240)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-11-28 | Sale | −30,000 | $0.21 | $6,150 | 826,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-11-28 | Sale | −10,000 | $0.20 | $2,000 | 816,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-11-28 | Sale | −7,000 | $0.21 | $1,470 | 809,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-11-28 | Sale | −10,000 | $0.17 | $1,700 | 799,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −10,000 | $0.20 | $2,000 | 789,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −15,000 | $0.19 | $2,850 | 774,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −30,000 | $0.19 | $5,550 | 744,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −45,000 | $0.16 | $6,975 | 699,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −5,000 | $0.16 | $800 | 694,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −5,000 | $0.15 | $725 | 689,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −5,000 | $0.15 | $770 | 684,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −10,000 | $0.18 | $1,800 | 674,572 | D |
| MANDELL HENRY R Chairman/CEO/CFO/Secretary | 2003-12-01 | Sale | −23,000 | $0.15 | $3,450 | 651,572 | D |
| Open-market sales · 205,000 sh · avg $0.18 · $36,240 | |||||||
Loading xslF345X02/bla15831_bla2hrm2.xml…